Activated γδ T cells inhibit osteoclast differentiation and resorptive activity in vitro

Clinical and Experimental Immunology

Volumn 174, Issue 2, 2013, Pages 281-291

  Pappalardo, A ^a   Thompson, K ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

T cells; CD4+ T cells; IFN ; Osteoclast; Osteoimmunology

Indexed keywords

CD28 ANTIGEN; CD3 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 17;

ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; GAMMA DELTA T LYMPHOCYTE; HUMAN; HUMAN CELL; OSTEOCLASTOGENESIS; OSTEOLYSIS; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

ΓΔ T CELLS; CD4+ T CELLS; IFN-Γ; OSTEOCLAST; OSTEOIMMUNOLOGY;

ANTIBODIES, BLOCKING; ARTHRITIS, RHEUMATOID; BONE RESORPTION; CD4-POSITIVE T-LYMPHOCYTES; CELL COMMUNICATION; CELL DIFFERENTIATION; CELLS, CULTURED; CYTOKINES; HUMANS; INFLAMMATION MEDIATORS; LYMPHOCYTE ACTIVATION; MACROPHAGE COLONY-STIMULATING FACTOR; OSTEOCLASTS; RANK LIGAND; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA;

EID: 84885157712     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/cei.12165     Document Type: Article

References (43)

1. Hattner R, Epker BN, Frost HM. Suggested sequential mode of control of changes in cell behaviour in adult bone remodelling. Nature 1965; 206:489-490.
2. Hattersley G, Owens J, Flanagan AM, Chambers TJ. Macrophage colony stimulating factor is essential for osteoclast formation in vitro. Biochem Biophys Res Commun 1991; 177:526-531.
3. Lacey DL, Timms E, Tan HL etal. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 1998; 93:165-176.
4. Kong YY, Feige U, Sarosi L etal. Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand. Nature 1999; 402:304-309.
5. Horwood NJ, Kartsogiannis V, Quinn JM, Romas E, Martin TJ, Gillespie MT. Activated T lymphocytes support osteoclast formation in vitro. Biochem Biophys Res Commun 1999; 265:144-150.
6. Takayanagi H, Ogasawara K, Hida S etal. T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-γ. Nature 2000; 408:600-605.
7. Kotake S, Udagawa N, Takahashi N etal. IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis. J Clin Invest 1999; 103:1345-1352.
8. Lam J, Takeshita S, Barker JE, Kanagawa O, Ross FP, Teitelbaum SL. TNF-α induces osteoclastogenesis of macrophages exposed to permissive levels of RANK ligand. J Clin Invest 2000; 106:14181-14188.
9. Hofbauer LC, Lacey DL, Dunstan CR, Spelsberg TC, Riggs BL, Khosla S. Interleukin-1β and tumor necrosis factor-α, but not interleukin-6, stimulate osteoprotegerin ligand gene expression in human osteobalstic cells. Bone 1999; 25:255-259.
10. Grcevic D, Lukic IK, Kovacic N, Ivcevic S, Katavic V, Marusic A. Activated T lymphocytes suppress osteoclastogenesis by diverting early monocyte/macrophage progenitor lineage commitment towards dendritic cell differentiation through down-regulation of receptor activator of nuclear factor-kappa and c-Fos. Clin Exp Immunol 2006; 146:146-158.
11. Stein NC, Kreutzmann C, Zimmermann SP etal. Interleukin-4 and interleukin-13 stimulate the osteoclast inhibitor osteoprotegerin by human endothelial cells through the STAT6 pathway. J Bone Miner Res 2008; 23:750-758.
12. + regulatory T cells inhibit the differentiation of osteoclasts from peripheral blood mononuclear cells. Biochem Biophys Res Commun 2007; 357:1046-1052.
13. Roark CL, French JD, Taylor MA, Bendele AM, Born WK, O'Brien RL. Exacerbation of collagen-induced arthritis by oligoclonal, IL-17-producing γδ T cells. J Immunol 2007; 179:5576-5583.
14. Hayday AC, Saito H, Gillies SD etal. Structure, organization and somatic rearrangement of T cell gamma genes. Cell 1985; 40:259-269.
15. Brennan FM, Londei M, Jackson AM etal. T cells expressing γδ chain receptors in rheumatoid arthritis. J Autoimmun 1988; 1:319-326.
16. Keystone EC, Rittershaus C, Wood N etal. Elevation of a γδ T cell subset in peripheral blood and synovial fluid of patients with rheumatoid arthritis. Clin Exp Immunol 1991; 84:78-82.
17. Ness-Schwickerath KJ, Jin C, Morita CT. Cytokine requirement for the differentiation of IL-17A- and IL-22-producing human Vgamma2Vdelta2 T cells. J Immunol 2010; 184:7268-7280.
18. Caccamo N, La Mendola C, Orlando V etal. Differentiation, phenotype, and function of interleukin-17-producing human Vg9Vd2 T cells. Blood 2011; 118:129-137.
19. Kunzmann V, Bauer E, Wilhelm M. Gamma/delta T-cell stimulation by pamidronate. N Engl J Med 1999; 340:737-738.
20. Thompson K, Rogers MJ. Statins prevent bisphosphonate-induced γδ-T-cell proliferation and activation in vitro. J Bone Miner Res 2004; 19:278-288.
21. Henriksen K, Karsdal MA, Taylor A, Tosh D, Coxon FP. Generation of human osteoclasts from peripheral blood. Methods Mol Biol 2012; 816:159-175.
22. Hermann P, Armant M, Brown E etal. The vitronectin receptor and its associated CD47 molecule mediates proinflammatory cytokine synthesis in human monocytes by interaction with soluble CD23. J Cell Biol 1999; 144:767-775.
23. Fujikawa Y, Sabokbar A, Neale S, Athanasou NA. Human osteoclast formation and bone resorption by monocytes and synovial macrophages in rheumatoid arthritis. Ann Rheum Dis 1996; 55:816-822.
24. Hewitt RE, Lissina A, Green AE, Slay ES, Price DA, Sewell AK. The bisphosphonate acute phase response: rapid and copious production of proinflammatory cytokines by peripheral blood γδ T cells in response to aminobisphosphonates is inhibited by statins. Clin Exp Immunol 2005; 139:101-111.
25. Sato K, Suematsu A, Okamoto K etal. Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction. J Exp Med 2006; 203:2673-2682.
26. Wyzga N, Varghese S, Wikel S, Canalis E, Sylvester FA. Effects of activated T cells on osteoclastogenesis depends on how they are activated. Bone 2004; 35:614-620.
27. DeBarros A, Chaves-Ferreira M, d'Orey F, Ribot J, Silva-Santos B. CD70-CD27 interactions provide survival and proliferative signals that regulate T cell receptor-driven activation of human γδ peripheral blood lymphocytes. Eur J Immunol 2011; 41:195-201.
28. Meliconi R, Pitzalis C, Kingsley GH, Panayi GS. γδ T cells and their subpopulations in blood and synovial fluids from rheumatoid arthritis and spondyloarthritis. Clin Immunol Immunopathol 1991; 59:165-172.
29. Kenna TJ, Davidson SI, Duan R etal. Enrichment of circulating interleukin-17-secreting interleukin-23 receptor-positive γδ T cells in patients with active ankylosing sponylitis. Arthritis Rheum 2012; 64:1420-1429.
30. + γδ T cells, drive arthritic bone destruction in mice and humans. J Immunol 2011; 186:2602-2612.
31. Ito Y, Usui T, Kobayashi S etal. Gamma/delta T cells are the predominant source of interleukin-17 in affected joints in collagen-induced arthritis but not in rheumatoid arthritis. Arthritis Rheum 2009; 60:2294-2303.
32. Kohara H, Kitaura H, Fujimura Y etal. IFN-γ directly inhibits TNF-α-induced osteoclastogenesis in vitro and in vivo and induces apoptosis mediated by Fas/Fas ligand interactions. Immunol Lett 2011; 137:53-61.
33. Ji JD, Park-Min KH, Shen Z etal. Inhibition of RANK expression and osteoclastogenesis by TLRs and IFN-γ in human osteoclast precursors. J Immunol 2009; 183:7223-7233.
34. Shioi A, Teitelbaum SL, Ross FP etal. Interleukin-4 inhibits murine osteoclast formation in vitro. J Cell Biochem 1991; 47:272-277.
35. Xu LX, Kukita T, Kukita A, Otsuka T, Niho Y, Iijima T. Interleukin-10 selectively inhibits osteoclastogenesis by inhibiting differentiation of osteoclast progenitors into preosteoclast-like cells in rat bone marrow culture system. J Cell Physiol 1995; 165:624-629.
36. Vermeire K, Heremans H, Vandeputte M, Huang S, Billiau A, Matthys P. Accelerated collagen-induced arthritis in IFN-γ receptor-deficient mice. J Immunol 1997; 158:5507-5513.
37. Key LL, Rodriguiz RM, Steve WM etal. Long-term treatment of osteopetrosis with recombinant human interferon gamma. N Engl J Med 1995; 332:1594-1599.
38. Gao Y, Grassi F, Ryan MR etal. IFN-γ stimulates osteoclast formation and bone loss in vivo via antigen-driven T cell activation. J Clin Invest 2007; 117:122-132.
39. Pang M, Martinez AF, Jacobs J, Balkan W, Troen BR. RANK ligand and interferon gamma differentially regulate cathepsin gene expression in pre-osteoclastic cells. Biochem Biophys Res Commun 2005; 328:756-763.
40. Thompson K, Roelofs A, Jauhiainen M, Monkkonnen H, Monkkonnen J, Rogers MJ. Activation of γδ T cells by bisphosphonates. Adv Exp Med Biol 2010; 658:11-20.
41. Welton JL, Morgan MP, Marti S etal. Monocytes and γδ T cells control the acute-phase response to intravenous zoledronate: insights from a phase IV safety trial. J Bone Miner Res 2013; 28:464-471.
42. Tanaka Y, Morita CT, Tanaka Y, Nieves E, Brenner MB, Bloom BR. Natural and synthetic non-peptide antigens recognized by human γδ T cells. Nature 1995; 375:155-158.
43. Roelofs AJ, Jauhiainen M, Monkkonen H, Rogers MJ, Monkkonen J, Thompson K. Peripheral blood monocytes are responsible for γδ T cell activation induced by zoledronic acid through accumulation of IPP/DMAPP. Br J Haematol 2009; 144:245-250.